Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about ENDOTHELIAL: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
ENDOTHELIAL is a concept in neurodegeneration research. Key relationships include: co discussed, activates, causes. Associated with ALS, ALZHEIMER, ATHEROSCLEROSIS. Connected to 168 entities in the SciDEX knowledge graph.
| Name | ENDOTHELIAL |
| Key Genes/Proteins | STAT3, P53, STING, GPX4, TNF, ROS |
| Related Diseases | FRONTOTEMPORAL DEMENTIA |
| Linked Hypotheses | 2 hypotheses |
Knowledge base pages for this entity
graph TD
ENDOTHELIAL["<b>ENDOTHELIAL</b>"]
ENDOTHELIAL -->|"causes"| INFLAMMATION["INFLAMMATION"]
ENDOTHELIAL -->|"contributes to"| IMMUNE_RESPONSE["IMMUNE RESPONSE"]
ENDOTHELIAL -->|"degrades"| FRONTOTEMPORAL["FRONTOTEMPORAL"]
ENDOTHELIAL -->|"degrades"| FTD["FTD"]
ENDOTHELIAL -->|"degrades"| GBA["GBA"]
ENDOTHELIAL -->|"causes"| HIF1A["HIF1A"]
ENDOTHELIAL -->|"activates"| JNK["JNK"]
ENDOTHELIAL -->|"interacts"| LC3["LC3"]
ENDOTHELIAL -->|"activates"| MAPK["MAPK"]
ENDOTHELIAL -->|"activates"| NLRP3["NLRP3"]
ENDOTHELIAL -->|"activates"| OPTN["OPTN"]
ENDOTHELIAL -->|"activates"| P62["P62"]
CD2AP["CD2AP"] -->|"causes"| ENDOTHELIAL
ALS["ALS"] -->|"activates"| ENDOTHELIAL
ALZHEIMER["ALZHEIMER"] -->|"activates"| ENDOTHELIAL
AMPK["AMPK"] -->|"activates"| ENDOTHELIAL
APOPTOSIS["APOPTOSIS"] -->|"regulates"| ENDOTHELIAL
AUTOPHAGY["AUTOPHAGY"] -->|"activates"| ENDOTHELIAL
BCL2["BCL2"] -->|"regulates"| ENDOTHELIAL
BECN1["BECN1"] -->|"interacts"| ENDOTHELIAL
CAT["CAT"] -->|"causes"| ENDOTHELIAL
DEMENTIA["DEMENTIA"] -->|"degrades"| ENDOTHELIAL| Target | Relation | Type | Str |
|---|---|---|---|
| T CELL | contributes_to | cell_type | 0.65 |
| NEUTROPHIL | increases | cell_type | 0.65 |
| STAT3 | activates | gene | 0.65 |
| NEURON | expressed_in | cell_type | 0.65 |
| P53 | interacts_with | gene | 0.65 |
| HIPPOCAMPUS | inhibits | brain_region | 0.65 |
| STING | increases | gene | 0.65 |
| P53 | activates | gene | 0.65 |
| GPX4 | interacts_with | gene | 0.65 |
| TNF | activates | gene | 0.65 |
| FRONTOTEMPORAL DEMENTIA | degrades | disease | 0.65 |
| ROS | activates | gene | 0.65 |
| STING | promotes | gene | 0.65 |
| METFORMIN | causes | drug | 0.65 |
| RAPAMYCIN | interacts_with | drug | 0.65 |
| GPX4 | ubiquitinates | gene | 0.65 |
| UBIQUITIN | ubiquitinates | gene | 0.65 |
| ROS | causes | gene | 0.65 |
| ROS | promotes | gene | 0.65 |
| MICROGLIA | inhibits | cell_type | 0.65 |
| RESVERATROL | targets | drug | 0.65 |
| NAD | regulates | gene | 0.65 |
| NEURODEGENERATION | phosphorylates | disease | 0.65 |
| TAU | phosphorylates | gene | 0.65 |
| MICROGLIA | activates | cell_type | 0.65 |
| NOTCH | regulates | gene | 0.65 |
| FRONTOTEMPORAL | degrades | disease | 0.60 |
| FTD | degrades | disease | 0.60 |
| GBA | degrades | gene | 0.60 |
| HIF1A | causes | gene | 0.60 |
| JNK | activates | gene | 0.60 |
| LC3 | interacts_with | gene | 0.60 |
| MAPK | activates | gene | 0.60 |
| NLRP3 | activates | gene | 0.60 |
| OPTN | activates | gene | 0.60 |
| P62 | activates | gene | 0.60 |
| PARKIN | activates | gene | 0.60 |
| PARKINSON | activates | disease | 0.60 |
| PINK1 | activates | gene | 0.60 |
| RAS | degrades | gene | 0.60 |
| RB1 | activates | gene | 0.60 |
| RIPK3 | activates | gene | 0.60 |
| SNCA | activates | gene | 0.60 |
| SQSTM1 | activates | gene | 0.60 |
| STING | activates | gene | 0.60 |
| UBIQUITIN | activates | gene | 0.60 |
| STROKE | associated_with | disease | 0.60 |
| OCLN | causes | gene | 0.60 |
| PERICYTE | contributes_to | cell_type | 0.60 |
| PERICYTES | contributes_to | cell_type | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ATHEROSCLEROSIS | causes | disease | 0.65 |
| CANCER | regulates | disease | 0.65 |
| ASTROCYTE | expressed_in | cell_type | 0.65 |
| ASTROCYTES | expressed_in | cell_type | 0.65 |
| ALZHEIMER | contributes_to | disease | 0.65 |
| ALZHEIMER'S | contributes_to | disease | 0.65 |
| ALZHEIMER'S DISEASE | contributes_to | disease | 0.65 |
| ATHEROSCLEROSIS | processes | disease | 0.65 |
| CD2AP | causes | gene | 0.60 |
| CD2AP | inhibits | gene | 0.60 |
| CD2AP | regulates | gene | 0.60 |
| ALS | activates | disease | 0.60 |
| ALZHEIMER | activates | disease | 0.60 |
| AMPK | activates | gene | 0.60 |
| BCL2 | regulates | gene | 0.60 |
| BECN1 | interacts_with | gene | 0.60 |
| CAT | causes | gene | 0.60 |
| DEMENTIA | degrades | disease | 0.60 |
| CLDN5 | regulates | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| CANCER | promotes | disease | 0.60 |
| DENDRITIC CELL | interacts_with | cell_type | 0.60 |
| ATG7 | causes | gene | 0.60 |
| AKT | interacts_with | gene | 0.60 |
| BAX | interacts_with | gene | 0.60 |
| BCL2 | interacts_with | gene | 0.60 |
| CREB | interacts_with | gene | 0.60 |
| BECN1 | activates | gene | 0.60 |
| CREB | activates | gene | 0.60 |
| ATHEROSCLEROSIS | contributes_to | disease | 0.60 |
| DIABETES | contributes_to | disease | 0.60 |
| AKT | causes | gene | 0.60 |
| AKT | targets | gene | 0.60 |
| ASTROCYTE | inhibits | cell_type | 0.60 |
| CHAT | interacts_with | gene | 0.60 |
| CHAT | causes | gene | 0.60 |
| APP | regulates | gene | 0.60 |
| BACE1 | regulates | gene | 0.60 |
| ASTROCYTE | treats | cell_type | 0.60 |
| ASTROCYTES | treats | cell_type | 0.60 |
| ASTROCYTE | promotes | cell_type | 0.60 |
| ASTROCYTES | promotes | cell_type | 0.60 |
| CXCL10 | promotes | gene | 0.60 |
| CD2AP | co_discussed | entity | 0.50 |
| ANGIOGENESIS | co_discussed | entity | 0.50 |
| AXON | co_discussed | entity | 0.50 |
| AUTOPHAGY | co_discussed | entity | 0.50 |
| BECN1 | co_discussed | entity | 0.50 |
| DEMENTIA | co_discussed | entity | 0.50 |
| BBB | co_discussed | entity | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Synthetic Biology BBB Endothelial Cell Reprogramming | 0.565 | neurodegeneration | Blood-brain barrier transport mechanisms |
| Endothelial Glycocalyx Regeneration via Syndecan-1 Upregulat | 0.505 | neurodegeneration | Perivascular spaces and glymphatic clear |
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| NETs induce ferroptosis of endothelial cells in LPS-ALI through SDC-1/HS and dow [PMID:38677244] | Fei Y, Huang X, Ning F, Qian T, Cui J, W | Biomed Pharmacother | 2024 | 1 |
| Protectin conjugates in tissue regeneration 1 restores lipopolysaccharide-induce [PMID:34217286] | Wang XY, Li XY, Wu CH, Hao Y, Fu PH, Mei | Respir Res | 2021 | 1 |
| The glycocalyx: a novel diagnostic and therapeutic target in sepsis. [PMID:30654825] | Uchimido R, Schmidt EP, Shapiro NI | Crit Care | 2019 | 1 |
| Pathogenic Significance of Serum Syndecan-1 and Syndecan-4 in Psoriasis. [PMID:41839009] | Yıldırım MA, Korkmaz S, Çelik HHA, Büyük | Cutis | 2026 | 0 |
| CD138 expression in the endometrium associates with endometrial timing and infla [PMID:41858134] | Odendaal J, Fishwick K, Correia GDS, Lee | Human reproduction (Oxford, En | 2026 | 0 |
| [Multicenter prospective study on the diagnostic value of syndecan-1 for necroti [PMID:41914411] | Yin XY, Zhao ZH, Wang Y, Cai N, Chen S | Zhongguo dang dai er ke za zhi | 2026 | 0 |
| Association of Viraemic Phase Viral Load, Antibody Responses, and Immune Biomark [PMID:41891425] | Alagarasu K, Gurav YK, Pulinchani A, Bac | Journal of medical virology | 2026 | 0 |
| Effect of Normothermic Machine Perfusion on Glycocalyx Shedding During Liver Tra [PMID:41847595] | Mathis S, Putzer G, Gasteiger L, Staier | Transplant international : off | 2026 | 0 |
| Cathepsin S is a novel target for age-related dry eye. [PMID:34910926] | ["Yu Z", "Li J", "Govindarajan G", "Hamm | Experimental eye research | 2022 | 0 |
| Ageing alters the lipid sensing process in the hypothalamus of Wistar rats. Effe [PMID:33544062] | ["Rodr\u00edguez M", "Pintado C", "Torri | Nutritional neuroscience | 2022 | 0 |
| Intrinsic functional neuron-type selectivity of transcranial focused ultrasound [PMID:33947867] | ["Yu K", "Niu X", "Krook-Magnuson E", "H | Nature communications | 2021 | 0 |
| NK cells for cancer immunotherapy. [PMID:31907401] | ["Shimasaki N", "Jain A", "Campana D"] | Nature reviews. Drug discovery | 2020 | 0 |
| Potent and specific MTH1 inhibitors targeting gastric cancer. [PMID:31164636] | ["Zhou W", "Ma L", "Yang J", "Qiao H", " | Cell death & disease | 2019 | 0 |
| Clinical factors associated with worse quality-of-life scores in United States t [PMID:30898373] | ["Goswami S", "Peipert B", "Mongelli M", | Surgery | 2019 | 0 |
| Syndecan-1 promotes lung fibrosis by regulating epithelial reprogramming through [PMID:31393853] | ["Parimon T", "Yao C", "Habiel D", "Ge L | JCI insight | 2019 | 0 |
| Arabidopsis Duodecuple Mutant of PYL ABA Receptors Reveals PYL Repression of ABA [PMID:29898403] | ["Zhao Y", "Zhang Z", "Gao J", "Wang P", | Cell reports | 2018 | 0 |
| Cell transplantation therapy for spinal cord injury. [PMID:28440805] | ["Assinck P", "Duncan G", "Hilton B", "P | Nature neuroscience | 2017 | 0 |
| Teacher development: a patchwork-text approach to enhancing critical reflection [PMID:24589866] | ["Silva-Fletcher A", "May H", "Magnier K | Journal of veterinary medical | 2014 | 0 |
| Genetics and phosphoproteomics reveal a protein phosphorylation network in the a [PMID:23572148] | ["Umezawa T", "Sugiyama N", "Takahashi F | Science signaling | 2013 | 0 |
| Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. [PMID:22343897] | ["Ichimura A", "Hirasawa A", "Poulain-Go | Nature | 2012 | 0 |